Related references
Note: Only part of the references are listed.Expression pattern of m6A regulators is significantly correlated with malignancy and antitumor immune response of breast cancer
Xiaofang He et al.
CANCER GENE THERAPY (2021)
The m6A epitranscriptome opens a new charter in immune system logic
Zhonghua Ma et al.
EPIGENETICS (2021)
Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy
Wenxiang Zhang et al.
FRONTIERS IN ONCOLOGY (2021)
HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy
Luke Maggs et al.
TRENDS IN CANCER (2021)
ALKBH5 Holds Prognostic Values and Inhibits the Metastasis of Colon Cancer
Peipei Yang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance
Qiang Wang et al.
GUT (2020)
Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy
Qinghua Wang et al.
AGING-US (2020)
Immune Escape during Breast Tumor Progression
Carlos R. Gil Del Alcazar et al.
CANCER IMMUNOLOGY RESEARCH (2020)
m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer
Bo Zhang et al.
MOLECULAR CANCER (2020)
The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinoma
Rong Tang et al.
PEERJ (2020)
YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis
Guoqiang Chang et al.
CANCER CELL (2020)
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression updates through inhibiting BNIP3
Yi Niu et al.
MOLECULAR CANCER (2019)
Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells
Dali Han et al.
NATURE (2019)
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao et al.
NATURE MEDICINE (2019)
Genomic correlates of response to immune checkpoint blockade
Tanya E. Keenan et al.
NATURE MEDICINE (2019)
Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation
Huamin Wang et al.
NATURE COMMUNICATIONS (2019)
Current Landscape of Immunotherapy in Breast Cancer: A Review
Sylvia Adams et al.
JAMA ONCOLOGY (2019)
KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner
Jia-Yi Qian et al.
ONCOGENE (2019)
Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity
Felix L. Fennemann et al.
FRONTIERS IN IMMUNOLOGY (2019)
Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
Shixiang Wang et al.
ELIFE (2019)
Functions of N6-methyladenosine and its role in cancer
Liuer He et al.
MOLECULAR CANCER (2019)
KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3
Tian Lan et al.
MOLECULAR CANCER (2019)
Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism
Ying Yang et al.
CELL RESEARCH (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways
Hua-Bing Li et al.
NATURE (2017)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Progressive loss of anti-HER2 CD4+ T-helper type 1 response in breast tumorigenesis and the potential for immune restoration
Jashodeep Datta et al.
ONCOIMMUNOLOGY (2015)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
Share Paper
